Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection-Reference-Cited by-同舟云学术

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection

Published:2020-06-30 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Sung Pil Soo,Jang Jeong Won,Lee Jaejun,Lee Soon Kyu,Lee Hae Lim,Yang Hyun,Nam Hee Chul,Lee Sung Won,Bae Si Hyun,Choi Jong Young,Han Nam Ik,Yoon Seung Kew

Funder

National Research Foundation of Korea

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference33 articles.

1. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang;Nat Rev Gastroenterol Hepatol.,2019

2. Reduction of intrahepatic tumour by hepatic arterial infusion chemotherapy prolongs survival in hepatocellular carcinoma;Sung;Anticancer Res.,2019

3. (18)F-fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment;Sung;Eur J Nucl Med Mol Imaging.,2018

4. Switching to systemic therapy after locoregional treatment failure: Definition and best timing;Ogasawara;Clin Mol Hepatol.,2020

5. Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions;Hilmi;J Immunother Cancer.,2019

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma;Biomarker Research;2024-02-14

2. Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma;Journal of Liver Cancer;2023-09-30

3. Blood biomarkers predict outcomes in patients with hepatocellular carcinoma treated with immune checkpoint Inhibitors: A pooled analysis of 44 retrospective sudies;International Immunopharmacology;2023-05

4. Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data;Frontiers in Oncology;2023-03-22

5. Site-Specific Differences in PD-1 Blockade Success and Biomarkers in Urothelial Carcinoma Treated with Pembrolizumab;Clinical Genitourinary Cancer;2023-02